Back
FlexShares Credit-Scored US Corp Bond Index Fund Vs. Bright Minds Biosciences Industry Stock Comparison
Sell
40
SKOR
FlexShares Credit-Scored US Corp Bond Index Fund
Last Price:
$47.71
Seasonality Move:
-0.57%
Sell
45
DRUG
Bright Minds Biosciences
Last Price:
$39.35
Seasonality Move:
-32.13%
Sell
40
FlexShares Credit-Scored US Corp Bond Index Fund (SKOR)
is a Sell
Is FlexShares Credit-Scored US Corp Bond Index Fund a Buy, Sell or Hold?
-
The current FlexShares Credit-Scored US Corp Bond Index Fund [SKOR] share price is $47.73. The Score for SKOR is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
SKOR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $39.85. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SKOR Stock Price Chart
What is FlexShares Credit-Scored US Corp Bond Index Fund's stock price today?
-
The FlexShares Credit-Scored US Corp Bond Index Fund share price today is $47.73Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKOR is experiencing slight selling pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $39.85Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
SKOR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 38.59 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.75 - 48.33) | Sell |
Bollinger Bands (100): | (48.01 - 48.89) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 51.96 | Buy |
Chaikin Money Flow: | 6916 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.23 - 42.31) | Buy |
Bollinger Bands (100): | (3.23 - 44.21) | Buy |
SKOR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.68 | Buy |
20-day SMA: | 47.98 | Sell |
50-day SMA: | 48.08 | Sell |
200-day SMA: | 47.97 | Sell |
8-day EMA: | 47.74 | Sell |
20-day EMA: | 47.89 | Sell |
50-day EMA: | 48.09 | Sell |
200-day EMA: | 48 | Sell |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.78 | Buy |
20-day SMA: | 38.81 | Buy |
50-day SMA: | 41.79 | Sell |
200-day SMA: | 12.42 | Buy |
8-day EMA: | 39 | Buy |
20-day EMA: | 39.09 | Buy |
50-day EMA: | 36.04 | Buy |
200-day EMA: | 18.43 | Buy |
FlexShares Credit-Scored US Corp Bond Index Fund Earnings Growth & SKOR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
FlexShares Credit-Scored US Corp Bond Index Fund Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
18 | 19 | 20 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |